Published in J Neurosci on February 01, 1992
The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80
Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev (2007) 6.36
Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature (2012) 5.37
The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol (2006) 3.97
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest (2006) 3.81
A unified framework for addiction: vulnerabilities in the decision process. Behav Brain Sci (2008) 2.83
Activation of VTA GABA neurons disrupts reward consumption. Neuron (2012) 2.80
Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology (2008) 2.80
Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci (2006) 2.80
How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron (2011) 2.50
Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area. Science (2011) 2.48
Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A (2006) 2.29
The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol (2007) 2.22
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol (2007) 2.18
The neurocircuitry of addiction: an overview. Br J Pharmacol (2008) 2.11
Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res (2008) 2.09
Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci (2011) 2.05
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol (2008) 1.99
The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) (2012) 1.96
Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. Drug Alcohol Depend (2012) 1.88
The role of GABA(A) receptors in the development of alcoholism. Pharmacol Biochem Behav (2008) 1.82
Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci (2010) 1.82
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Forebrain substrates of reward and motivation. J Comp Neurol (2005) 1.72
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. Psychopharmacology (Berl) (2003) 1.66
Ultrastructural analysis of local collaterals of rat ventral tegmental area neurons: GABA phenotype and synapses onto dopamine and GABA cells. Synapse (2009) 1.64
Ventral tegmental area glutamate neurons: electrophysiological properties and projections. J Neurosci (2012) 1.57
OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend (2010) 1.55
The mechanistic classification of addictive drugs. PLoS Med (2006) 1.54
Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci (2009) 1.50
Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A (1996) 1.49
Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry (2005) 1.47
Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal. J Neurosci (2015) 1.47
Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. J Neurosci (2012) 1.42
Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol Ther (2009) 1.42
Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br J Pharmacol (1994) 1.41
Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci (2011) 1.41
Stress, alcohol and drug interaction: an update of human research. Addict Biol (2008) 1.40
Glutamate neurons within the midbrain dopamine regions. Neuroscience (2014) 1.35
Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl) (2003) 1.31
Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol (2004) 1.30
Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J Physiol (2011) 1.30
The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. Biol Psychiatry (2010) 1.27
Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest (2012) 1.26
In vivo neurochemical monitoring using benzoyl chloride derivatization and liquid chromatography-mass spectrometry. Anal Chem (2011) 1.26
Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA. J Neurosci (2013) 1.26
Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis (2012) 1.25
Energy regulatory signals and food reward. Pharmacol Biochem Behav (2010) 1.25
Neuronal circuits underlying acute morphine action on dopamine neurons. Proc Natl Acad Sci U S A (2011) 1.23
A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) (2003) 1.23
Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol (2009) 1.22
Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron (2011) 1.21
The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum. Genome Biol (2010) 1.20
Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology (Berl) (2007) 1.20
Long-lasting alteration in mesocorticolimbic structures after repeated social defeat stress in rats: time course of mu-opioid receptor mRNA and FosB/DeltaFosB immunoreactivity. Eur J Neurosci (2008) 1.20
GABAergic and glutamatergic efferents of the mouse ventral tegmental area. J Comp Neurol (2014) 1.19
Ethanol enhances GABAergic transmission onto dopamine neurons in the ventral tegmental area of the rat. Alcohol Clin Exp Res (2008) 1.19
Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev (2009) 1.18
Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Br J Pharmacol (1994) 1.18
Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice. Psychopharmacology (Berl) (2003) 1.15
Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons. J Physiol (2003) 1.15
Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology (2011) 1.14
The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways. Neurosci Biobehav Rev (2013) 1.14
Sensitization of ventral tegmental area dopamine neurons to the stimulating effects of ethanol. Alcohol Clin Exp Res (2009) 1.13
Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci (2011) 1.13
Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci (2008) 1.11
Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones. J Physiol (1997) 1.11
Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors. Neuroscience (2008) 1.11
A possible mechanism underlying the effectiveness of acupuncture in the treatment of drug addiction. Evid Based Complement Alternat Med (2008) 1.09
Environmental enrichment decreases the rewarding but not the activating effects of heroin. Psychopharmacology (Berl) (2008) 1.09
Role of 5-hydroxytryptamine2C receptors in Ca2+-dependent ethanol potentiation of GABA release onto ventral tegmental area dopamine neurons. J Pharmacol Exp Ther (2009) 1.09
Optogenetic modulation of neural circuits that underlie reward seeking. Biol Psychiatry (2011) 1.09
Identification of rat ventral tegmental area GABAergic neurons. PLoS One (2012) 1.09
Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J Neurosci (2010) 1.08
Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat. Psychopharmacology (Berl) (2012) 1.08
Opiate drug use and the pathophysiology of neuroAIDS. Curr HIV Res (2012) 1.07
Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J Neurophysiol (2006) 1.07
New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system. J Neurosci (2013) 1.07
A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. Neuropsychopharmacology (2010) 1.07
Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. Int Rev Neurobiol (2010) 1.05
Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation. Neuroscience (2008) 1.04
Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area. J Neurosci (2010) 1.04
Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol Disord Drug Targets (2008) 1.03
Discrete cell gene profiling of ventral tegmental dopamine neurons after acute and chronic cocaine self-administration. J Pharmacol Exp Ther (2003) 1.03
Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol Psychiatry (2012) 1.03
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems. Pharmacol Rev (2016) 1.02
Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology (2012) 1.02
Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms. Eur J Neurosci (2009) 1.02
VTA GABA neurons modulate specific learning behaviors through the control of dopamine and cholinergic systems. Front Behav Neurosci (2014) 1.02
PKG and PKA signaling in LTP at GABAergic synapses. Neuropsychopharmacology (2009) 1.02
Targeted expression of μ-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward. Nat Neurosci (2014) 1.02
Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci U S A (2006) 1.01
Drug context differently regulates cocaine versus heroin self-administration and cocaine- versus heroin-induced Fos mRNA expression in the rat. Psychopharmacology (Berl) (2009) 1.00
The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci U S A (2004) 1.00
Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron (2013) 0.99
Morphine produces circuit-specific neuroplasticity in the bed nucleus of the stria terminalis. Neuroscience (2008) 0.99
The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior. Neurosci Biobehav Rev (2010) 0.99
Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci (2012) 0.99
Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice. Genes Brain Behav (2009) 0.99
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (1996) 7.10
Intracellular recording from the myenteric plexus of the guinea-pig ileum. J Physiol (1973) 5.49
A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature (1994) 5.43
Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature (1995) 5.38
Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature (1991) 4.84
Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity (2001) 4.23
Calcium-activated potassium channels expressed from cloned complementary DNAs. Neuron (1992) 4.06
Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol (1992) 3.98
Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci (1996) 3.71
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG (2013) 2.83
Pore dilation of neuronal P2X receptor channels. Nat Neurosci (1999) 2.81
Withdrawal of nifedipine capsules: jeopardizing the treatment of acute severe hypertension in pregnancy? Australasian Society for the Study of Hypertension in Pregnancy. Med J Aust (1997) 2.78
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem (1997) 2.78
Tetraethylammonium block of Slowpoke calcium-activated potassium channels expressed in Xenopus oocytes: evidence for tetrameric channel formation. Pflugers Arch (1994) 2.75
Multiple subunits of a voltage-dependent potassium channel contribute to the binding site for tetraethylammonium. Neuron (1992) 2.74
Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol (1987) 2.65
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol Pharmacol (1995) 2.50
Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A (1987) 2.48
An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J (1996) 2.48
Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol (2000) 2.47
Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci (1989) 2.40
Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol (1999) 2.37
Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J (2001) 2.34
Membrane properties of rat locus coeruleus neurones. Neuroscience (1984) 2.29
Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology (1997) 2.24
5-HT3 receptors are membrane ion channels. Nature (1989) 2.21
Interaction between tetraethylammonium and amino acid residues in the pore of cloned voltage-dependent potassium channels. J Biol Chem (1991) 2.18
Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor. J Biol Chem (2000) 2.08
Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J Physiol (1996) 2.07
The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) (2010) 2.06
P2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci (1995) 2.05
On the potassium conductance increased by opioids in rat locus coeruleus neurones. J Physiol (1985) 2.04
Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science (1992) 2.02
Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J (1997) 2.02
Expression of a cloned rat brain potassium channel in Xenopus oocytes. Science (1989) 1.99
Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology (1997) 1.96
The calcium-activated potassium conductance in guinea-pig myenteric neurones. J Physiol (1982) 1.94
Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors. Mol Pharmacol (1998) 1.91
Tissue distribution of the P2X7 receptor. Neuropharmacology (1997) 1.90
Depression of calcium-dependent potassium conductance of guinea-pig myenteric neurones by muscarinic agonists. J Physiol (1983) 1.88
The calcium-dependent slow after-hyperpolarization in myenteric plexus neurones with tetrodotoxin-resistant action potentials. Br J Pharmacol (1973) 1.88
Slow synaptic potentials in neurones of the myenteric plexus. J Physiol (1980) 1.87
Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci U S A (1996) 1.86
P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur J Neurosci (1998) 1.85
Inhibitory synaptic potentials resulting from alpha 2-adrenoceptor activation in guinea-pig submucous plexus neurones. J Physiol (1985) 1.85
Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol Pharmacol (1987) 1.80
On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. J Physiol (1988) 1.79
Somatostatin increases an inwardly rectifying potassium conductance in guinea-pig submucous plexus neurones. J Physiol (1987) 1.76
Substantia gelatinosa neurones hyperpolarized in vitro by enkephalin. Nature (1983) 1.74
Functional differences among alternatively spliced variants of Slowpoke, a Drosophila calcium-activated potassium channel. J Biol Chem (1994) 1.73
Does substance P mediate slow synaptic excitation within the myenteric plexus? Nature (1978) 1.72
Contribution of individual subunits to the multimeric P2X(2) receptor: estimates based on methanethiosulfonate block at T336C. Mol Pharmacol (1999) 1.70
Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J Biol Chem (1993) 1.66
Muscarinic agonists inactivate potassium conductance of guinea-pig myenteric neurones. J Physiol (1982) 1.66
The action of substance P on neurons of the myenteric plexus of the guinea-pig small intestine. Proc R Soc Lond B Biol Sci (1979) 1.66
Opiate-receptor interactions on single locus coeruleus neurones. Mol Pharmacol (1984) 1.66
The mechanism of action of narcotic analgesics in the guinea-pig ileum. Br J Pharmacol (1977) 1.63
Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience (1985) 1.60
Enkephalin opens potassium channels on mammalian central neurones. Nature (1982) 1.60
Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol (1996) 1.59
Cooperative interactions among subunits of a voltage-dependent potassium channel. Evidence from expression of concatenated cDNAs. J Biol Chem (1992) 1.59
Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system. J Physiol (1985) 1.57
Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X(2) receptor. J Biol Chem (2001) 1.55
Heteropolymeric potassium channels expressed in Xenopus oocytes from cloned subunits. Neuron (1990) 1.55
Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. J Neurophysiol (1997) 1.54
Acetylcholine hyperpolarizes central neurones by acting on an M2 muscarinic receptor. Nature (1986) 1.53
Electrophysiology of the enteric nervous system. Neuroscience (1982) 1.51
Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. J Physiol (1983) 1.49
Current inactivation involves a histidine residue in the pore of the rat lymphocyte potassium channel RGK5. Biochem Biophys Res Commun (1991) 1.49
Membrane properties and synaptic responses of rat striatal neurones in vitro. J Physiol (1991) 1.48
Domains of P2X receptors involved in desensitization. Proc Natl Acad Sci U S A (1996) 1.46
Electrical coupling synchronizes subthreshold activity in locus coeruleus neurons in vitro from neonatal rats. J Neurosci (1989) 1.46
Neurobiology of opiate abuse. Trends Pharmacol Sci (1992) 1.44
Anticoagulation in pregnancy and the puerperium. Med J Aust (2001) 1.42
Single amino acid substitution affects desensitization of the 5-hydroxytryptamine type 3 receptor expressed in Xenopus oocytes. Proc Natl Acad Sci U S A (1993) 1.41
Pregnancy in women with primary focal and segmental hyalinosis and sclerosis. Clin Nephrol (1988) 1.39
Clonidine activates membrane potassium conductance in myenteric neurones. Br J Pharmacol (1981) 1.39
Electrophysiology of opioids. Pharmacol Rev (1983) 1.38
The action of 5-hydroxytryptamine on single neurones of the rabbit superior cervical ganglion. Neuropharmacology (1978) 1.36
The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro. J Physiol (1984) 1.36
Opioids increase potassium conductance in submucous neurones of guinea-pig caecum by activating delta-receptors. Br J Pharmacol (1986) 1.35
Mu and kappa opioids inhibit transmitter release by different mechanisms. Proc Natl Acad Sci U S A (1985) 1.34
Muscarinic presynaptic inhibition of synaptic transmission in myenteric plexus of guinea-pig ileum. J Physiol (1982) 1.34
Mechanism of synaptic inhibition by noradrenaline acting at alpha 2-adrenoceptors. Proc R Soc Lond B Biol Sci (1988) 1.33
Membrane topology of an ATP-gated ion channel (P2X receptor). J Biol Chem (1998) 1.32
Muscarinic synaptic potentials in guinea-pig myenteric plexus neurones. J Physiol (1982) 1.31
Multiple actions of 5-hydroxytryptamine on myenteric neurones of the guinea-pig ileum. J Physiol (1980) 1.30
Mediators of slow synaptic potentials in the myenteric plexus of the guinea-pig ileum. J Physiol (1981) 1.30
Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons. Neurosci Lett (1992) 1.30
Inward rectification of resting and opiate-activated potassium currents in rat locus coeruleus neurons. J Neurosci (1988) 1.28
Actions of cocaine on rat dopaminergic neurones in vitro. Br J Pharmacol (1990) 1.27
Effects of ecotropic murine retroviruses on the dual-function cell surface receptor/basic amino acid transporter. J Biol Chem (1992) 1.27
Opiate activation of potassium conductance in myenteric neurons: inhibition by calcium ion. Brain Res (1982) 1.26
Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women. Ultrasound Obstet Gynecol (2000) 1.26
On the mechanism and site of action of enkephalin on single myenteric neurons. Brain Res (1979) 1.26
Opiates and enkephalin reduce the excitability of neuronal processes. Neuroscience (1981) 1.25
Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol (1989) 1.24